NIR Group

[APennyPrincess]

Medgen, NIR & Noveshen connection - you were right PD they were all playing the game together. Press release below is dated April 19, 2005. On either April 5 or 7, 2005 Noveshen hurriedly signed a marital settlement agreement with his first wife because he wanted to sign it before his huge windfall of cash came in from his consulting fees from the deal he put together for NIR to fund Medgen. If the exwife found out he had the kind of money he made from that deal her child support would have doubled. Wonder if anyone paid taxes on all of this LOL.

http://www.businesswire.com/news/home/20050419005299/en/Med-Gen-Attracts-Investment-NIR-Group#.VePeiNq9KK0

BOCA RATON, Fla.--(BUSINESS WIRE)--April 19, 2005--Med Gen Inc. (OTCBB:MDGN), manufacturers of the national brands Snorenz(R), snore relief throat spray and Good Nights Sleep(R), sleep aid throat spray, announced today that it has secured financing from the NIR Group of Roslyn, New York and various participating Investment Funds.

The Investment totals $1,540,000 of gross proceeds, with most of the proceeds being used for marketing of Snorenz(R) and Good Nights Sleep(R), the development of Appease(TM), the company's new throat spray dietary brand and Radio and TV advertising programs to support its brands already being sold in leading chains.

“, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.”

The funding, which is in the form of a three year 8% Convertible Debenture and Warrants to convert 1,540,000 shares at $0.085, consists of three tranches of $740,000 and two equal tranches of $400,000. The first tranche was received by the company on March 31, 2005. The second and third tranches will be funded upon, (i) the filing of a registration statement and, (ii) the effectiveness of the registration. The debenture is immediately convertible into shares of common stock at any time during the term, but at no time can the conversion result in ownership that would exceed 4.9% of the issued and outstanding shares of the company's stock. The terms that control the conversion of the debenture and the number of shares that can be converted at any-one-time, in effect, are protective of the company's shares from any down spiraling due to the unloading of a large number of shares at any one time. Other protective covenants prohibit the shorting of the Company's common stock For a more complete review of the funding documents please visit the government web site EDGAR.com.

By extending this opportunity to Med Gen, the NIR Group has shown its confidence in the future of Med Gen and in its management as well as the efficacy of its present and future products and its unique "sprays the way", technology.

This Press Release contains or incorporates by reference "forward looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MDGN".